Direct delivery of syngeneic and allogeneic large-scale expanded multipotent adult progenitor cells improves cardiac function after myocardial infarct

References

• Anversa P, Rota M, Urbanek K, et al. Myocardial aging: a stem cell problem. Basic Res Cardiol 2005; 100: 482–93
   PubMedGoogle Scholar
• Askari AT, Unzek S, Popovic ZB, et al. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 2003; 362: 697–703
   PubMed Web of Science ®Google Scholar
• Penn MS, Zhang M, Deglurkar I, Topol EJ. Role of stem cell homing in myocardial regeneration. Int J Cardiol 2004; 95(Suppl 1)S23–5
   PubMed Web of Science ®Google Scholar
• Murry CE, Field LJ, Menasche P. Cell-based cardiac repair: reflections at the 10-year point. Circulation 2005; 112: 3174–83
   PubMed Web of Science ®Google Scholar
• Orlic, D. BM stem cells and cardiac repair: where do we stand in 2004?. 2005;7:3–15
   Google Scholar
• Penn MS, Francis GS, Ellis SG, et al. Autologous cell transplantation for the treatment of damaged myocardium. Prog Cardiovasc Dis 2002; 45: 21–32
   PubMed Web of Science ®Google Scholar
• Welt FG, Losordo DW. Cell therapy for acute myocardial infarction: curb your enthusiasm?. Circulation 2006; 113: 1272–4
   PubMed Web of Science ®Google Scholar
• Vandervelde S, van Luyn MJ, Tio RA, Harmsen MC. Signaling factors in stem cell-mediated repair of infarcted myocardium. J Mol Cell Cardiol 2005; 39: 363–76
   PubMed Web of Science ®Google Scholar
• Laflamme MA, Murry CE. Regenerating the heart. Nat Biotechnol 2005; 23: 845–56
   PubMed Web of Science ®Google Scholar
• Balsam LB, Wagers AJ, Christensen JL, et al. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 2004; 428: 668–73
   PubMed Web of Science ®Google Scholar
• Murry CE, Soonpaa MH, Reinecke H, et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004; 428: 664–8
   PubMed Web of Science ®Google Scholar
• Lee MS, Lill M, Makkar RR. Stem cell transplantation in myocardial infarction. Rev Cardiovasc Med 2004; 5: 82–98
   Google Scholar
• Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001; 410: 701–5
   PubMed Web of Science ®Google Scholar
• Amado LC, Saliaris AP, Schuleri KH, et al. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci USA 2005; 102: 11474–9
   PubMed Web of Science ®Google Scholar
• Yoon YS, Wecker A, Heyd L, et al. Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J Clin Invest 2005; 115: 326–38
   PubMed Web of Science ®Google Scholar
• Pittenger MF, Martin BJ. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 2004; 95: 9–20
   PubMed Web of Science ®Google Scholar
• Murry CE, Reinecke H, Pabon LM. Regeneration gaps: observations on stem cells and cardiac repair. J Am Coll Cardiol 2006; 47: 1777–85
   PubMed Web of Science ®Google Scholar
• Assmus B, Schachinger V, Teupe C, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 2002; 106: 3009–17
   PubMed Web of Science ®Google Scholar
• Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002; 418: 41–9
   PubMed Web of Science ®Google Scholar
• Mays RW, Van't Hof W, Ting A, et al. Development of adult pluripotent stem cell therapies for ischemic injury and disease. Expert Opin Biol Ther 2007; 7: 173–84
   PubMed Web of Science ®Google Scholar
• Reyes M, Lund T, Lenvik T, et al. Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood 2001; 98: 2615–25
   PubMed Web of Science ®Google Scholar
• Kovacsovics-Bankowski, M, Streeter, PR, Mauch, KA, , et al. Clinical scale expanded multipotent adult progenitor cells are immunoprivileged and suppress lymphocyte responses, Submitted. 2007
   Google Scholar
• Askari A, Unzek S, Goldman CK, et al. Cellular, but not direct, adenoviral delivery of vascular endothelial growth factor results in improved left ventricular function and neovascularization in dilated ischemic cardiomyopathy. J Am Coll Cardiol 2004; 43: 1908–14
   PubMedGoogle Scholar
• Zeng L, Hu Q, Wang X, et al. Bioenergetic and functional consequences of bone marrow derived multipotent progenitor cell transplantation in hearts with postinfarction LV remodeling. Circulation 2007; 115: 1866–75
   PubMed Web of Science ®Google Scholar
• Coultas L, Chawengsaksophak K, Rossant J. Endothelial cells and VEGF in vascular development. Nature 2005; 438: 937–45
   PubMed Web of Science ®Google Scholar
• Jiang Y, Vaessen B, Lenvik T, et al. Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain. Exp Hematol 2002; 30: 896–904
   PubMed Web of Science ®Google Scholar
• Keene CD, Ortiz-Gonzalez XR, Jiang Y, et al. Neural differentiation and incorporation of bone marrow-derived multipotent adult progenitor cells after single cell transplantation into blastocyst stage mouse embryos. Cell Transplant 2003; 12: 201–13
   PubMed Web of Science ®Google Scholar
• Serafini M, Dylla SJ, Oki M, et al. Hematopoietic reconstitution by multipotent adult progenitor cells: precursors to long-term hematopoietic stem cells. J Exp Med 2007; 204: 129–39
   PubMed Web of Science ®Google Scholar
• Muguruma Y, Reyes M, Nakamura Y, et al. In vivo and in vitro differentiation of myocytes from human bone marrow-derived multipotent progenitor cells. Exp Hematol 2003; 31: 1323–30
   PubMed Web of Science ®Google Scholar
• Kogler G, Sensken S, Airey JA, et al. A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med 2004; 200: 123–35
   PubMed Web of Science ®Google Scholar
• D'Ippolito G, Diabira S, Howard GA, et al. Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential. J Cell Sci 2004; 117: 2971–81
   PubMed Web of Science ®Google Scholar
• Anjos-Afonso F, Bonnet D. Nonhematopoietic/endothelial SSEA-1+ cells define the most primitive progenitors in the adult murine bone marrow mesenchymal compartment. Blood 2007; 109: 1298–306
   PubMed Web of Science ®Google Scholar
• Kucia M, Reca R, Campbell FR, et al. A population of very small embryonic-like (VSEL) CXCR4(+)SSEA-1(+)Oct-4+ stem cells identified in adult bone marrow. Leukemia 2006; 20: 857–69
   PubMed Web of Science ®Google Scholar
• Tolar J, Nauta AJ, Osborn MJ, et al. Sarcoma derived from cultured mesenchymal stem cells. Stem Cells 2007; 25: 371–9
   PubMed Web of Science ®Google Scholar
• Yoon YS, Park JS, Tkebuchava T, et al. Unexpected severe calcification after transplantation of bone marrow cells in acute myocardial infarction. Circulation 2004; 109: 3154–7
   PubMed Web of Science ®Google Scholar
• Kim BO, Tian H, Prasongsukarn K, et al. Cell transplantation improves ventricular function after a myocardial infarction: a preclinical study of human unrestricted somatic stem cells in a porcine model. Circulation 2005; 112: 96–104
   PubMed Web of Science ®Google Scholar
• Makkar RR, Price MJ, Lill M, et al. Intramyocardial injection of allogenic bone marrow-derived mesenchymal stem cells without immunosuppression preserves cardiac function in a porcine model of myocardial infarction. J Cardiovasc Pharmacol Ther 2005; 10: 225–33
   PubMed Web of Science ®Google Scholar
• Dai W, Hale SL, Kloner RA. Stem cell transplantation for the treatment of myocardial infarction. Transpl Immunol 2005; 15: 91–7
   PubMedGoogle Scholar
• Dai W, Hale SL, Martin BJ, et al. Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects. Circulation 2005; 112: 214–23
   PubMed Web of Science ®Google Scholar
• Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143–7
   PubMed Web of Science ®Google Scholar
• Agbulut O, Mazo M, Bressolle C, et al. Can bone marrow-derived multipotent adult progenitor cells regenerate infarcted myocardium?. Cardiovasc Res 2006; 72: 175–83
   PubMed Web of Science ®Google Scholar
• Yoon YS, Johnson IA, Park JS, et al. Therapeutic myocardial angiogenesis with vascular endothelial growth factors. Mol Cell Biochem 2004; 264: 63–74
   PubMedGoogle Scholar
• Yoon YS, Murayama T, Gravereaux E, et al. VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema. J Clin Invest 2003; 111: 717–25
   PubMedGoogle Scholar